Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Stockholders' Equity (Deficit)

v3.22.1
Consolidated Statements Of Stockholders' Equity (Deficit) - USD ($)
shares in Thousands
Preferred Stock [Member]
Common Stock [Member]
Common Shares Issuable [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 3,000 $ 4,000 $ 548,184,000 $ (567,501,000) $ (19,310,000)
Beginning balance, shares at Dec. 31, 2019 2,450 4,105      
Fair value of amended convertible notes and warrants 8,643,000 8,643,000
Issuance of common and warrants for settlement of litigation 2,246,000 2,246,000
Issuance of common and warrants for settlement of litigation, shares 262        
Beneficial conversion feature on convertible notes payable 5,274,000 5,274,000
Common shares issued upon conversion of notes payable $ 1,000 1,740,000 1,741,000
Common shares issued upon conversion of notes payable, shares 512        
Common shares issued upon exercise of warrants
Common shares issued upon exercise of warrants, shares 240        
Issuance of common stock for compensation 269,000 269,000
Issuance of common stock for compensation, shares 99        
Net loss (28,296,000) (28,296,000)
Ending balance, value at Dec. 31, 2020 $ 3,000 $ 5,000 566,356,000 (595,797,000) (29,433,000)
Ending balance, shares at Dec. 31, 2020 2,450 5,218      
Extinguishment of debt discount upon adoption of ASU 2020-06 (4,745,000) 226,000 (4,519,000)
Conversion of Preferred Series J-1 to common stock $ (2,000) $ 1,000 1,000
Conversion of Preferred Series J-1 to common stock, shares (2,354) 692        
Common shares issued upon mandatory conversion of notes payable and accrued interest $ 11 $ 1,113 37,675 38,799
Common shares issued upon mandatory conversion of notes payable and accrued interest, shares 11,086 327      
Common shares issued upon exercise of warrants $ 3,000 16,430,000 16,433,000
Common shares issued upon exercise of warrants, shares 3,074        
Issuance of common stock in public offering, net of cost $ 5,000 24,674,000 24,679,000
Issuance of common stock in public offering, net of cost, shares 4,945        
Issuance of common stock for research and development agreement 1,355,000 1,355,000
Issuance of common stock for research and development agreement, shares 190      
Issuance of common stock for services $ 3,000 15,337,000 15,340,000
Issuance of common stock for services, shares 3,082        
Equity compensation to officers, board of directors and employees $ 4,000 17,230,000 17,234,000
Equity compensation to officers and board of directors, shares 3,775        
Extinguishment of derivative liability 35,000 35,000
Net loss (58,013,000) (58,013,000)
Ending balance, value at Dec. 31, 2021 $ 1,000 $ 32,000 $ 1,113,000 $ 674,348,000 $ (653,584,000) $ 21,910,000
Ending balance, shares at Dec. 31, 2021 96 32,062 327